141 related articles for article (PubMed ID: 21865371)
1. Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer.
Capezzone M; Cantara S; Marchisotta S; Busonero G; Formichi C; Benigni M; Capuano S; Toti P; Pazaitou-Panayiotou K; Caruso G; Carli AF; Palummo N; Pacini F
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1852-6. PubMed ID: 21865371
[TBL] [Abstract][Full Text] [Related]
2. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
Capezzone M; Cantara S; Marchisotta S; Filetti S; De Santi MM; Rossi B; Ronga G; Durante C; Pacini F
J Clin Endocrinol Metab; 2008 Oct; 93(10):3950-7. PubMed ID: 18664542
[TBL] [Abstract][Full Text] [Related]
3. Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma.
Jendrzejewski J; Tomsic J; Lozanski G; Labanowska J; He H; Liyanarachchi S; Nagy R; Ringel MD; Kloos RT; Heerema NA; de la Chapelle A
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1876-80. PubMed ID: 21900378
[TBL] [Abstract][Full Text] [Related]
4. Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.
Caria P; Cantara S; Frau DV; Pacini F; Vanni R; Dettori T
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775641
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.
Malchoff CD; Sarfarazi M; Tendler B; Forouhar F; Whalen G; Joshi V; Arnold A; Malchoff DM
J Clin Endocrinol Metab; 2000 May; 85(5):1758-64. PubMed ID: 10843148
[TBL] [Abstract][Full Text] [Related]
6. Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres.
Cantara S; Capuano S; Capezzone M; Benigni M; Pisu M; Marchisotta S; Pacini F
Thyroid; 2012 Apr; 22(4):363-8. PubMed ID: 22304389
[TBL] [Abstract][Full Text] [Related]
7. Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer.
Cantara S; Pisu M; Frau DV; Caria P; Dettori T; Capezzone M; Capuano S; Vanni R; Pacini F
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1327-31. PubMed ID: 22539583
[TBL] [Abstract][Full Text] [Related]
8. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
[TBL] [Abstract][Full Text] [Related]
9. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
10. Familial thyroid carcinoma: a diagnostic algorithm.
Dotto J; Nosé V
Adv Anat Pathol; 2008 Nov; 15(6):332-49. PubMed ID: 18948764
[TBL] [Abstract][Full Text] [Related]
11. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment.
Musholt TJ; Musholt PB; Petrich T; Oetting G; Knapp WH; Klempnauer J
World J Surg; 2000 Nov; 24(11):1409-17. PubMed ID: 11038215
[TBL] [Abstract][Full Text] [Related]
12. [Familial papillary thyroid carcinoma].
Ji Q; Wu Y; Zhu Y; Wang Y; Zhang R; Luo Z
Zhonghua Wai Ke Za Zhi; 2002 Aug; 40(8):564-6. PubMed ID: 12417064
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.
Cao J; Chen C; Chen C; Wang QL; Ge MH
Clin Endocrinol (Oxf); 2016 Apr; 84(4):598-606. PubMed ID: 26191611
[TBL] [Abstract][Full Text] [Related]
14. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
15. Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour.
Pinto AE; Silva GL; Henrique R; Menezes FD; Teixeira MR; Leite V; Cavaco BM
Eur J Endocrinol; 2014 Feb; 170(2):321-7. PubMed ID: 24272198
[TBL] [Abstract][Full Text] [Related]
16. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
17. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
18. A report of six cases of familial papillary thyroid cancer.
Orsenigo E; Beretta E; Gini P; Verrecchia F; Invernizzi L; Fiorina P; Di Carlo V
Eur J Surg Oncol; 2003 Mar; 29(2):185-7. PubMed ID: 12633563
[TBL] [Abstract][Full Text] [Related]
19. Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation.
Pusztaszeri MP; Sadow PM; Faquin WC
Cancer Cytopathol; 2013 Apr; 121(4):206-13. PubMed ID: 23042745
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
